1 Results (Page 1 of 1)
US Free Markets Research Reports
Pharmaceuticals
US Breast Cancer Market Analysis Sample Report
The US breast cancer market is expected to witness growth from $473 Mn in 2022 to $1,083 Mn in 2030 with a CAGR of 10.9% for the year 2022-2030. Increased prevalence of breast cancer and technologically advanced therapeutics are the major growth drivers for the expansion of the market in US.
LAST UPDATED: Jan, 1970